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Abstract 
Introduction: Alcohol use is an independent risk factor for liver metastasis, a major cause of morbidity 
and mortality in colorectal cancer (CRC) patients. Serum CEA level is an established prognostic indicator 
in CRC, yet the correlation with behavioral factors such as alcohol use remains to be defined. In a single-
center review, we evaluated alcohol use, gender, and CEA levels in predicting advanced disease in CRC 
patients. 
Methods: Retrospective analysis of UNMC patients diagnosed with CRC as the primary cancer between 
2012-2019, stages I-IV, and age >19 with documentation of alcohol use. Univariable statistics were 
performed using Chi-Square and non-parametric tests. Associations between stage, gender, and alcohol 
use (some vs. none) and the log-transformed CEA outcome (either initial or rate of change) were 
assessed using linear regressions. 
Results: Alcohol use was found to be reported in 333 of 1243 CRC patients. The cohort was comprised of 
192 male and 141 female subjects. Elevated CEA levels at CRC diagnosis were associated with increased 
all-cause mortality (33.0% for CEA > 3.4ng/ml vs 10.4% for CEA < 3.4ng/ml). Model analysis found that 
stage IV male alcohol users showed an increase in serial CEA levels compared to males who did not use 
alcohol, but this pattern was not observed among stage IV females. 
Conclusions: Males with a history of alcohol use may be at risk for advanced CRC disease suggesting the 
utility of serial serum CEA monitoring in these patients. A detailed alcohol use history should be obtained 
in all patients with CRC as it has prognostic value and may allow for early intervention. This analysis was 
limited by missing alcohol use data for the majority (73.2%) of CRC patients evaluated. A prospective 
study is warranted to define the implications of alcohol use and risk of CRC liver metastasis. 
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Abstract
Introduction: Alcohol use is an independent 
risk factor for liver metastasis, a major cause 
of morbidity and mortality in colorectal 
cancer (CRC) patients. Serum CEA level is 
an established prognostic indicator in CRC, 
yet the correlation with behavioral factors 
a single-center review, we evaluated alcohol 
use, gender, and CEA levels in predicting 
advanced disease in CRC patients.
Methods: Retrospective analysis of UNMC 
patients diagnosed with CRC as the primary 
and age >19 with documentation of alcohol 
use. Univariable statistics were performed 
using Chi-Square and non-parametric tests. 
Associations between stage, gender, and 
alcohol use (some vs. none) and the log-
transformed CEA outcome (either initial or 
rate of change) were assessed using linear 
regressions.
Results: Alcohol use was found to be 
reported in 333 of 1243 CRC patients. The 
cohort was comprised of 192 male and 141 
female subjects. Elevated CEA levels at CRC 
diagnosis were associated with increased 
all-cause mortality (33.0% for CEA > 3.4ng/
ml vs 10.4% for CEA < 3.4ng/ml). Model 
users showed an increase in serial CEA levels 
compared to males who did not use alcohol, 
but this pattern was not observed among stage 
Conclusions: Males with a history of alcohol 
use may be at risk for advanced CRC disease 
suggesting the utility of serial serum CEA 
monitoring in these patients. A detailed 
alcohol use history should be obtained in all 
patients with CRC as it has prognostic value 
and may allow for early intervention. This 
analysis was limited by missing alcohol use 
data for the majority (73.2%) of CRC patients 
evaluated. A prospective study is warranted to 
of CRC liver metastasis.
Introduction
Colorectal cancer (CRC) is the 3rd most 
common cancer worldwide, and in the U.S. 
alone, accounts for over 50,000 deaths 
annually.1 CRC mortality is primarily due to 
the development of colorectal liver metastasis 
(CRLM).2-3 Over 50% of CRC patients will 
either present with synchronous disease or 
later develop metachronous liver metastases 
during their disease course.4 Despite 
advancements in surgical interventions and 
chemotherapeutics, CRLM is associated 
with poorer outcomes, emphasizing the 
monitor the spread of disease. While there are 
continued extensive efforts to optimize CRC 
screening, we are lacking an understanding 
of methods to identify patients at risk for 
development of CRLM. This is especially 
evident in patient populations with an alcohol 
use history that may correlate with advanced 
CRC disease and CRLM-associated mortality.
71-90% whereas those with metastatic liver 
disease have 14% survival.5 This profound 
decrease in survival rates demonstrates 
the necessity to identify patients at risk for 
development of metastatic disease, especially 
CRLM because the liver is the predominant 
site of CRC spread. Alcohol abuse is known 
to contribute to 6% of the World deaths 
with approximately 12% of those deaths 
being associated with alcohol-related 
carcinogenesis. Other lifestyle habits such 
as smoking and consumption of red meat are 
also associated with CRC burden.6-8 However, 
alcohol consumption, in particular, has been 
CRLM and a factor associated with poorer 
prognosis of CRC patients.8-10 Alcohol use 
initial CRC diagnosis as well as with hepatic 
metastases that occur throughout the disease 
course.10-11 Preclinical studies have shown 
that the alcohol-injured liver is susceptible 
to developing CRLM earlier and to a greater 
extent compared to healthy liver.12-16
Clinical assessments have shown that CRC 
patients with an alcohol use history often 
require intensive follow-up due to reduced 
liver function, unresectable hepatic lesions, 
and poor survival rates.6, 17-18 However, 
few reports exist concerning alcohol and 
CRLM risk in the U.S. indicating the need 
consumption in CRC burden. Moreover, 
recent studies indicate an alarming increase 
in the rate of morbidity and mortality from 
alcohol use disorders and related diseases in 
the U.S.19 This is especially evident as alcohol 
use patterns such as heavy and episodic 
binge drinking may have a profound impact 
on disease burden and healthcare costs. As a 
result, there is a call for focused public health 
strategies to address alcohol misuse and to 
characterize the role of alcohol consumption 
as a predisposing factor to CRLM in high-risk 
populations. 
The Midwest region of the US has one of the 
highest incidence rates of CRC as well as 
heavy and binge drinking prevalence.1, 20-21 
The aberrant use of alcohol is estimated 
to contribute to the higher incidence of 
CRC with evidence indicating that heavy 
drinking increases the risk of CRC mortality.6 
Additionally, the elevated risk of poor 
outcomes of CRC appear higher for men 
compared to women at similar levels of 
alcohol exposure. The male gender has also 
been established as an independent risk factor 
for incidence of CRLM.4, 22-23 Altogether, the 
level of alcohol consumption prior to CRC 
factor not only for cancer development but for 
poor outcomes as well. The geographic and 
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combined assessments of cancer biomarkers 
and alcohol consumption. 
The potential of serum carcinoembryonic 
antigen (CEA) as a measure of advanced CRC 
has been demonstrated in both preclinical 
and clinical studies.11, 14, 24-25 As a result, 
serum CEA levels are routinely monitored 
in CRC patients and it is well established 
that elevated levels correlate with advanced 
disease.24-25
found to be increased in >80% of patients 
with distant metastasis with serial CEA 
measures used as a detection method for 
CRLM.24 However, the monitoring of CEA 
as an exclusive biomarker has been long-
debated in that 30-40% of CRC patients at 
initial diagnosis do not have elevated serum 
CEA values.26 Moreover, it is not known if 
gender differences exist for serum CEA levels 
in relationship to advanced CRC disease. 
Thus, current research efforts are evaluating 
the role of combination measures of serum 
biomarkers, biochemical parameters, and 
lifestyle habits for better follow-up and early 
this single-institution retrospective study, we 
evaluated the associations of gender, alcohol 
use, and stage with CEA levels in CRC 
patients at the University of Nebraska Medical 
Center (UNMC). We hypothesized that the 
combination of these variables may be utilized 
to identify at-risk populations for CRLM in a 
region that has a high incidence of CRC and 
alcohol use disorders. 
Methods
Patient Population: We performed a 
retrospective analysis of UNMC patients 
diagnosed with CRC between 2012-2019. 
Data were obtained from the UNMC clinical 
data warehouse (CDW), an i2b2-based 
data repository (https://www.i2b2.org/), 
internally referred to as CRANE (Clinical 
Research Analytics Environment). The i2b2 
data is populated using information from 
the Electronic Medical Record (EMR). The 
inclusion criteria included CRC as the primary 
>19; and treatment at UNMC. The data 
extracted included gender; history of alcohol 
use, liver enzymes, serum CEA, and date 
of death or last follow-up. This study was 
Review Board. 
Data Characteristics and Statistical 
Analysis: A population of 1,243 CRC patients 
CRANE database. Only twenty-seven percent 
of the total CRC patients had a documented 
alcohol use history and were included 
between subgroups of variables of interest 
were assessed using Kruskal-Wallis tests, 
and Wilcoxon Rank Sum tests for post-hoc 
pairwise comparisons, or Chi-Square tests 
when CEA was dichotomized (i.e., Low: CEA 
< 3.4; High: CEA >= 3.4). For modeling, 
initial CEA values were log transformed due 
change in CEA over time, the difference in 
CEA)) were divided by the length of follow 
up, to give the average difference in log 
CEA values per year. For both log of initial 
CEA value and average annual change in 
the log values of CEA as outcomes, a triple 
interaction between stage, gender, and alcohol 
use was assessed using linear regression 
models, which adjusted for relevant lower 
order interactions and main effects, as well 
as initial log CEA for the change model only. 
investigated by assessing gender by alcohol 
use interactions in separate models, one for 
main effects were assessed with Bonferroni 
or Tukey’s post-hoc adjusted pairwise 
comparisons, respectively. All analyses were 
performed using SAS software version 9.4 
Results
Patient Characteristics: The patient 
population evaluated in this study is shown in 
in the CRANE database as CRC patients of 
all stages at UNMC between the years of 
2012-2019. Three hundred and thirty-three 
patients (26.7%) had information on alcohol 
use (dichotomized as either no or some use) 
that was recorded in the EMR. This cohort 
evaluated was comprised of 192 male and 
141 female subjects. Alcohol use did not 
fewer females reported alcohol use (27.7%) 
compared to males (44.3%), p= 0.002.
Analysis of Alcohol Use and Serum CEA 
levels: A linear regression analysis of the 
log of serum CEA levels recorded near or at 
the date of CRC diagnosis (initial CEA) is 
represented in Fig. 2. The triple interaction 
between stage, gender, and alcohol use was 
serum CEA values (i.e., at time of CRC 
as expected. 
The utility of CEA measures as a prognostic 
indicator of advanced disease and likely 
CRLM is further emphasized by the analysis 
of mortality and the initial recorded measure 
of CEA in the patient cohort (Fig. 3). The 
data indicate that elevated measures of 
initial serum CEA levels are associated with 
increased all-cause mortality (33.0% for CEA 
> 3.4ng/ml vs 10.4% for CEA < 3.4ng/ml, p < 
0.0001). Finally, an assessment of the yearly 
change in log serum CEA values over time 
between gender, stage, and alcohol use 
(p=0.01). To further assess this relationship, 
Figure 1. Flow diagram of the single-institution retrospective analysis of colorectal cancer patients with 
alcohol-use data.
CRC patients (Stage I – V)
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the gender by alcohol two-way interaction 
was assessed in separate models, one for each 
stage. This interaction between gender and 
in log CEA between the two alcohol use 
men in this stage who used alcohol had a 
than men who did not (p = 0.02) (Fig. 4).
Alcohol intake is a well-established risk factor 
for primary CRC.27-28 Alcohol consumption 
has also been shown to be an independent 
risk factor of CRLM and poorer prognosis 
of CRC patients.9-10, 18 The current literature 
supports that alcohol creates a hepatic 
microenvironment susceptible to tumor cell 
seeding and growth.13-15, 29 However, few 
reports exist concerning alcohol and CRLM 
of data in Midwest states such as Nebraska 
that report high rates of alcohol use disorders 
and risk of colorectal cancers1, 20-21 which 
prompted this retrospective analysis of alcohol 
use in CRC patients treated at the University 
of Nebraska Medical Center.
Recent studies indicate an alarming increased 
rate of morbidity and mortality from alcohol 
use disorders in the U.S. with the call for 
focused public health strategies to address this 
serious situation.6, 18-19
has recommended that patients should be 
Table 1.
Patient Characteristics, Alcohol use 
(n) Alcohol use 
(some)
Alcohol use  
(none)
P-value
Total CRC patients with alcohol use documented 333 124 209
























Figure 2. Triple interaction between stage, gender, alcohol use (none vs some) and initial CEA values 
the other two stage groups (p<0.0001). NAACCR, North American Association of Central Cancer 
Registries Stages I, II/III and IV.
Figure 3. CRC mortality in relationship to 
initial serum CEA values. The percentage of 
CRC patients (alive or deceased) compared 
to the serum CEA levels obtained at initial visit 
following colorectal cancer diagnosis.
Figure 4.
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questioned about the pattern of alcohol 
consumption in addition to the number of 
drinks consumed.30 At UNMC, the Electronic 
Medical Record (EMR) alcohol history 
includes frequency of alcohol use, drinks per 
occasion, and type of alcohol (wine, beer, 
liquor). However, questions are lacking for 
the presence of binge episodes and prior 
consumption patterns. Further, a review of 
the EMR data at our institution indicates that 
alcohol use data is not recorded in discrete 
some EMR records contain physician notes 
concerning alcohol consumption, this data 
agreement with this review, the current 
retrospective analysis determined that only 
were found to have alcohol use information 
in the i2B2 repository. Additionally, the 
majority of records reporting alcohol use were 
not complete in relation to number of drinks 
and type of alcohol consumed. As a result, 
this study was only able to report alcohol 
use as none or some alcohol consumed. This 
limitation associated with poor documentation 
of alcohol use at UNMC is also observed 
as a widespread problem seen in across 
institutions worldwide; several analyses have 
demonstrated that alcohol use history and 
diagnoses of alcohol use disorder are greatly 
under documented in the EMR.31-33 This is a 
major concern as alcohol use data could prove 
to be meaningful in the investigations of 
several disease processes, including colorectal 
cancer. 
Despite the limitation of missing alcohol use 
data, the relationship of alcohol use history, 
CRC stage, and tumor marker measures was 
assessed in a cohort of 333 CRC patients. 
The tumor marker studied was CEA, a 
glycoprotein of the immunoglobulin gene 
family that codes for several tumorigenic 
adhesion proteins.34 CEA serum measures 
have proven to be a useful marker for CRC 
assessment of prognosis and liver metastasis.35 
Studies indicate that patients with high 
preoperative CEA serum concentrations 
(>5 ng/ml) have worse outcomes as well as 
disease recurrence.35-37
with distant metastasis and the measure of 
serial CEA levels over time is used as an 
accurate detection method for CRLM.17, 24 
The results of our retrospective analysis are 
consistent with reports for the use of CEA 
as a marker for advanced disease.26, 38 CEA 
and mortality correlated with elevated serum 
initial CEA values compared to serial CEA 
measures in relationship to behavioral and 
environmental factors such as alcohol use. 
Furthermore, it is unclear if CEA levels 
differ between men and women and what 
role a history of alcohol consumption might 
play. Our data indicates that initial, likely 
advanced disease stage (i.e. CRLM) with 
minimal increases in CEA levels seen after 
initial diagnosis in early disease stages (i.e. 
24, 26, 38 Further, in this study with 
limited alcohol use data, we were not able to 
show an association between alcohol use and 
initial CEA serum values during any stage of 
CRC disease. Future analyses are needed to 
determine if such a relationship exists. 
With respect to gender differences, this 
study indicates a potential role of alcohol 
use and serial CEA values in males with 
advanced CRC disease. This is clinically 
relevant as the incidence and mortality of 
colorectal cancer is known to be higher in 
males.1, 39 Several retrospective, population-
based studies have also found male gender 
to be a risk factor for both synchronous and 
metachronous liver metastases.4, 22-23 However, 
for CRC diagnosis or monitoring based on 
current society guidelines. This includes 
initial screening for CRC and surveillance 
disease following resection.35, 40 The present 
analysis found that male alcohol users with 
serial CEA levels than males who did not use 
alcohol, a pattern that was not seen in stage 
that male sex, alcohol use, and elevated CEA 
levels are each independent risk factors for 
the presence of metastatic liver disease. Thus, 
males with a history of alcohol use should 
be recognized as a high-risk population 
for metastatic involvement and serial CEA 
monitoring may have increased utility in these 
patients.
associated with increased average annual 
in the small subset of patients where alcohol 
use was documented. Considering the growing 
burden of alcohol related disease, further 
investigation regarding the implications of 
alcohol use on development of CRLM may 
be clinically meaningful and demonstrate the 
importance of obtaining alcohol use data in 
CRC patients. Given the substantial mortality 
associated with CRLM, research efforts are 
needed to focus on identifying vulnerable 
patients. A detailed alcohol use history should 
be obtained in all patients with CRC as it has 
prognostic value. Our retrospective analysis 
was limited by missing alcohol use data for 
a majority of patients treated for CRC. A 
prospective study is warranted for a better 
regards to the implications of alcohol use on 
liver metastases in CRC. 
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